| scholarly article | Q13442814 |
| P50 | author | John C. Morris | Q56839763 |
| P2860 | cites work | Mild Cognitive Impairment Can Be Distinguished From Alzheimer Disease and Normal Aging for Clinical Trials | Q22253054 |
| Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q24595802 | ||
| Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
| Mild cognitive impairment: clinical characterization and outcome | Q28140626 | ||
| The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q29547554 | ||
| The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q29614406 | ||
| Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria | Q29614408 | ||
| The Clinical Dementia Rating (CDR): current version and scoring rules | Q29616280 | ||
| Mild cognitive impairment as a diagnostic entity | Q29619568 | ||
| The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers | Q31081008 | ||
| Hospital-diagnosed dementia and suicide: a longitudinal study using prospective, nationwide register data | Q31148169 | ||
| The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery | Q33454243 | ||
| Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease | Q33560183 | ||
| Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization | Q33601338 | ||
| Evidence of neurodegeneration in brains of older adults who do not yet fulfill MCI criteria. | Q33624213 | ||
| Memantine and acetylcholinesterase inhibitor treatment in cases of CDR 0.5 or questionable impairment | Q33684234 | ||
| Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. | Q33697980 | ||
| MCI is associated with deficits in everyday functioning | Q33893620 | ||
| Mild cognitive impairment represents early-stage Alzheimer disease | Q33938635 | ||
| Are memory complaints predictive for dementia? A review of clinical and population-based studies | Q34103134 | ||
| Reimagining Alzheimer's disease--an age-based hypothesis | Q34155080 | ||
| Lack of evidence for the efficacy of memantine in mild Alzheimer disease. | Q34177515 | ||
| The Informant Questionnaire on cognitive decline in the elderly (IQCODE): a review | Q34370393 | ||
| Ascertainment Bias in the Clinical Diagnosis of Alzheimer Disease | Q34392486 | ||
| Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience | Q34429537 | ||
| Telling the truth: what do general practitioners say to patients with dementia or terminal cancer? | Q34469336 | ||
| Global clinical dementia rating of 0.5 in MCI masks variability related to level of function | Q34647104 | ||
| Counting dementia: There is no one "best" way | Q35096832 | ||
| The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition | Q35484657 | ||
| Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment | Q35868499 | ||
| Adding Delayed Recall to the Alzheimer Disease Assessment Scale is Useful in Studies of Mild Cognitive Impairment But Not Alzheimer Disease | Q36478298 | ||
| Frequency and course of mild cognitive impairment in a multiethnic community | Q36643547 | ||
| Mild cognitive impairment--a confused concept? | Q36728584 | ||
| Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment | Q36969034 | ||
| Mild cognitive impairment: believe it or not? | Q37299901 | ||
| Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease | Q37332710 | ||
| Amyloid-dependent and amyloid-independent stages of Alzheimer disease | Q37863977 | ||
| Ten-year risk of dementia in subjects with mild cognitive impairment | Q79215665 | ||
| Mild cognitive impairment: long-term course of four clinical subtypes | Q79453139 | ||
| Restriction in complex activities of daily living in MCI: impact on outcome | Q80071444 | ||
| Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI | Q80071452 | ||
| Mild cognitive impairment | Q81018633 | ||
| Disclosing the diagnosis of dementia: the performance of Flemish general practitioners | Q81409490 | ||
| Mild cognitive impairment is early-stage Alzheimer disease: time to revise diagnostic criteria | Q82214340 | ||
| Impaired financial abilities in mild cognitive impairment: a direct assessment approach | Q38430036 | ||
| The prediction of Alzheimer disease. The role of patient and informant perceptions of cognitive deficits | Q39113698 | ||
| Reaction to a dementia diagnosis in individuals with Alzheimer's disease and mild cognitive impairment | Q39325063 | ||
| Perceptions of Illness, coping, and well-being in persons with mild cognitive impairment and their care partners | Q40077357 | ||
| The value of informant versus individual's complaints of memory impairment in early dementia | Q40735083 | ||
| Spouse caregivers' attitudes toward obtaining a diagnosis of a dementing illness | Q40932984 | ||
| Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. | Q42462476 | ||
| What belgian neurologists and neuropsychiatrists tell their patients with Alzheimer disease and why: a national survey | Q42664935 | ||
| Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree? | Q43538075 | ||
| Mild cognitive impairment in the elderly: predictors of dementia | Q43742864 | ||
| Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain | Q44810166 | ||
| Early dementia diagnosis and the risk of suicide and euthanasia | Q46653677 | ||
| EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives | Q46832663 | ||
| Early Alzheimer's disease. Diagnostic considerations | Q48104761 | ||
| Argyrophilic grain disease in demented subjects presenting initially with amnestic mild cognitive impairment | Q48493664 | ||
| Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype | Q48499517 | ||
| Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging | Q48748346 | ||
| Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease | Q48790608 | ||
| Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. | Q48963534 | ||
| Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease | Q49103500 | ||
| Conversion to dementia from mild cognitive disorder: the Cache County Study. | Q50721674 | ||
| Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline. | Q50786678 | ||
| Prediction of All-Cause Dementia Using Neuropsychological Tests within 10 and 5 Years of Diagnosis in a Community-Based Sample | Q51034696 | ||
| Benefit of the Awaji diagnostic algorithm for amyotrophic lateral sclerosis: a prospective study. | Q51045774 | ||
| Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. | Q51125007 | ||
| Early intervention for mild cognitive impairment: a randomised controlled trial. | Q51937625 | ||
| Memory decline in healthy older people: implications for identifying mild cognitive impairment. | Q51966132 | ||
| Subjective memory complaints, white-matter lesions, depressive symptoms, and cognition in elderly patients. | Q51989760 | ||
| Measurement of functional activities in older adults in the community. | Q52098675 | ||
| Screening for early dementia using memory complaints from patients and relatives. | Q52104920 | ||
| Interrater reliability of the Clinical Dementia Rating in a multicenter trial. | Q52921970 | ||
| Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study. | Q53316825 | ||
| Family members favor disclosing the diagnosis of Alzheimer's disease. | Q53374037 | ||
| Early-stage Alzheimer disease represents increased suicidal risk in relation to later stages. | Q53375917 | ||
| The effects of preclinical dementia on estimates of normal cognitive functioning in aging | Q71169247 | ||
| Visual memory predicts Alzheimer's disease more than a decade before diagnosis | Q73229989 | ||
| Classification criteria for mild cognitive impairment: a population-based validation study | Q73371507 | ||
| P433 | issue | 6 | |
| P921 | main subject | mild cognitive impairment | Q1472703 |
| Alzheimer's disease | Q11081 | ||
| dementia | Q83030 | ||
| cognitive dysfunction | Q57859955 | ||
| P304 | page(s) | 700-708 | |
| P577 | publication date | 2012-06-01 | |
| P1433 | published in | Archives of Neurology | Q15766672 |
| P1476 | title | Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia | |
| P478 | volume | 69 |
| Q50874163 | A new approach to the characterization of subtle errors in everyday action: implications for mild cognitive impairment. |
| Q96950768 | A pilot study of brain morphometry following donepezil treatment in mild cognitive impairment: volume changes of cortical/subcortical regions and hippocampal subfields |
| Q47123869 | Activities of daily living measured by the Harvard Automated Phone Task track with cognitive decline over time in non-demented elderly |
| Q36755789 | Activities of daily living: where do they fit in the diagnosis of Alzheimer's disease? |
| Q38161786 | Alzheimer disease therapy--moving from amyloid-β to tau. |
| Q36632807 | Alzheimer's disease diagnostic criteria: practical applications |
| Q50669564 | Apolipoprotein E alleles in Cuban patients with mild cognitive impairment. |
| Q35884245 | Application and Revision of Montreal Cognitive Assessment in China's Military Retirees with Mild Cognitive Impairment |
| Q37069527 | Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association |
| Q27345258 | Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research Results |
| Q33792226 | Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer's disease |
| Q37141912 | Changes in cerebral morphometry and amplitude of low-frequency fluctuations of BOLD signals during healthy aging: correlation with inhibitory control |
| Q48706392 | Classification and localization of early-stage Alzheimer's disease in magnetic resonance images using a patch-based classifier ensemble |
| Q37035720 | Clinical implications of the new diagnostic guidelines for dementia |
| Q37044224 | Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease |
| Q93197689 | Correlation Between Cognition and Balance Among Middle-Aged and Older Adults Observed Through a Tai Chi Intervention Program |
| Q37042753 | Daily Activity Abilities in MCI, Alzheimer's Disease, and Healthy Controls |
| Q37693936 | Definitions of dementia and predementia states in Alzheimer's disease and vascular cognitive impairment: consensus from the Canadian conference on diagnosis of dementia |
| Q34587724 | Everyday cognition scale items that best discriminate between and predict progression from clinically normal to mild cognitive impairment |
| Q46195489 | Family Caregivers of Older Adults, 1999-2015: Trends in Characteristics, Circumstances, and Role-Related Appraisal. |
| Q35662685 | Functional Activities Questionnaire Items that Best Discriminate and Predict Progression from Clinically Normal to Mild Cognitive Impairment |
| Q38890671 | Functional Disability in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis |
| Q38532673 | Informing Understandings of Mild Cognitive Impairment for Older Adults: Implications From a Scoping Review. |
| Q48056416 | Interview with Dr John Morris, 28 February 2013. |
| Q88075568 | Linear Combinations of Multiple Outcome Measures to Improve the Power of Efficacy Analysis ---Application to Clinical Trials on Early Stage Alzheimer Disease |
| Q39199521 | Living Alone With Cognitive Impairment. |
| Q34964670 | MRS in mild cognitive impairment: early differentiation of dementia with Lewy bodies and Alzheimer's disease |
| Q90571674 | Marital status and cognitive impairment in the United States: evidence from the National Health and Aging Trends Study |
| Q60912308 | Measuring instrumental activities of daily living in non-demented elderly: a comparison of the new performance-based Harvard Automated Phone Task with other functional assessments |
| Q34622731 | Medial temporal lobe function during emotional memory in early Alzheimer's disease, mild cognitive impairment and healthy ageing: an fMRI study |
| Q40144248 | Mild cognitive impairment: clinical and imaging profile in a memory clinic setting in India |
| Q58729501 | Modified Criteria for Diagnosing "Cognitive Frailty" |
| Q36445708 | P300 and neuropsychological assessment in mild cognitive impairment and Alzheimer dementia |
| Q36652102 | Pain in Community-Dwelling Older Adults with Dementia: Results from the National Health and Aging Trends Study |
| Q33772053 | Physical activity and brain function in older adults at increased risk for Alzheimer's disease |
| Q37022754 | Potentially Unsafe Activities and Living Conditions of Older Adults with Dementia |
| Q37653889 | Recent updates on subcortical ischemic vascular dementia |
| Q44896850 | Reduced frontal activation during a working memory task in mild cognitive impairment: a non-invasive near-infrared spectroscopy study. |
| Q33953180 | Regional cortical thinning and cerebrospinal biomarkers predict worsening daily functioning across the Alzheimer's disease spectrum |
| Q34047125 | Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrum |
| Q37691963 | Rethinking the Food and Drug Administration's 2013 guidance on developing drugs for early-stage Alzheimer's disease |
| Q34180267 | SIST-M-IR activities of daily living items that best discriminate clinically normal elderly from those with mild cognitive impairment |
| Q49918788 | Salient Cues and Wayfinding in Alzheimer's Disease within a Virtual Senior Residence |
| Q38630139 | Self-perceived Difficulties in Everyday Function Precede Cognitive Decline among Older Adults in the ACTIVE Study. |
| Q38743343 | Systematic Review of Model-Based Economic Evaluations of Treatments for Alzheimer's Disease |
| Q38592066 | Targeting Cognitive Frailty: Clinical and Neurobiological Roadmap for a Single Complex Phenotype |
| Q51064883 | Tau-PET Binding Distinguishes Patients With Early-stage Posterior Cortical Atrophy From Amnestic Alzheimer Disease Dementia. |
| Q46956095 | Telephone screening for mild cognitive impairment in hispanics using the Alzheimer's questionnaire |
| Q36351683 | The Harvard Automated Phone Task: new performance-based activities of daily living tests for early Alzheimer's disease |
| Q38410298 | The Potential Utility of Eye Movements in the Detection and Characterization of Everyday Functional Difficulties in Mild Cognitive Impairment. |
| Q37417895 | The apolipoprotein E genotype predicts longitudinal transitions to mild cognitive impairment but not to Alzheimer's dementia: findings from a nationally representative study |
| Q88625808 | Using Base Rate of Low Scores to Identify Progression from Amnestic Mild Cognitive Impairment to Alzheimer's Disease |
| Q36787196 | Which part of the Quick mild cognitive impairment screen (Qmci) discriminates between normal cognition, mild cognitive impairment and dementia? |
Search more.